mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-08 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-08 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |